Financhill
Sell
35

STOK Quote, Financials, Valuation and Earnings

Last price:
$8.15
Seasonality move :
19.76%
Day range:
$7.66 - $8.35
52-week range:
$5.80 - $17.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.27x
P/B ratio:
1.97x
Volume:
1.1M
Avg. volume:
793.9K
1-year change:
39.07%
Market cap:
$450.5M
Revenue:
$36.6M
EPS (TTM):
-$1.68

Earnings Data

Next earnings date for STOK
May 06
2025
Most recent earnings per share
-$0.18
Beat by $0.35
(Mar 18/2025)
Consensus Estimate
-$0.53
(Mar 18/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STOK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/06/2025 Q1 $5.3M -- -- -$0.48 --
03/18/2025 Q4 $4.3M $22.6M -$0.18 -$0.53 $0.35
11/05/2024 Q3 $3.6M $4.9M -$0.47 -$0.54 $0.07
08/07/2024 Q2 $3.3M $4.8M -$0.46 -$0.56 $0.10
05/06/2024 Q1 $3.2M $4.2M -$0.57 -$0.61 $0.04
03/25/2024 Q4 $3.2M $2.8M -$0.60 -$0.63 $0.03
11/07/2023 Q3 -- -- -$0.55 -$0.65 $0.10
08/07/2023 Q2 -- -- -$0.69 -$0.66 -$0.03
05/04/2023 Q1 -- -- -$0.53 -$0.72 $0.19
03/10/2023 Q4 -- -- -$0.65 -$0.71 $0.06
11/14/2022 Q3 -- -- -$0.66 -$0.68 $0.02
08/08/2022 Q2 -- -- -$0.63 -$0.69 $0.06
05/10/2022 Q1 -- -- -$0.66 $0.13 -$0.79
03/10/2022 Q4 -- -- -$0.66 -$0.61 -$0.05
11/08/2021 Q3 -- -- -$0.61 -$0.55 -$0.06
08/10/2021 Q2 -- -- -$0.60 -$0.46 -$0.14
05/10/2021 Q1 -- -- -$0.46 -$0.44 -$0.02
03/09/2021 Q4 -- -- -$0.42 -$0.42 $0.00
11/12/2020 Q3 -- -- -$0.41 -$0.43 $0.02
08/10/2020 Q2 -- -- -$0.39 -$0.36 -$0.03
05/15/2020 Q1 -- -- -$0.34 -$0.37 $0.03
03/23/2020 Q4 -- -- -$0.31 -$0.30 -$0.01
11/12/2019 Q3 -- -- -$0.26 -$0.28 $0.02
08/14/2019 Q2 -- -- -$1.54 -$1.63 $0.09

Stoke Therapeutics Earnings Questions

  • How Much did Stoke Therapeutics Generate in Revenue Last Quarter?

    Stoke Therapeutics reported $22.6M worth of top line sales in its most recent quarter.

  • Did Stoke Therapeutics Beat Earnings Last Quarter?

    Stoke Therapeutics announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.53 per share.

  • Is Stoke Therapeutics Profitable?

    Stoke Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Stoke Therapeutics EPS Next Year?

    Stoke Therapeutics's earnings are forecast to decrease from -$1.65 per share to -$2.02 per share next year representing a decrease of -20.36%.

  • When is Stoke Therapeutics's Earnings Date?

    Stoke Therapeutics's next earnings date is May 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 21

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Buy
95
EXOD alert for Mar 21

Exodus Movement [EXOD] is up 1.11% over the past day.

Sell
15
FG alert for Mar 21

F&G Annuities & Life [FG] is down 4.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock